AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • 2025 Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

New in SAj: Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses

Mar 18, 2022 by AMERSA

In “Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses,” authors McKenna C. Eastment, MD, MPH, Ayushi Gupta, MS, MBA, Jocelyn James, MD, Barbra A. Richardson, PhD, Leeya Pinder, MD, MPH, H. Nina Kim, MD, MSc, Anna Wald MD, MPH, and Judith I. Tsui , MD, MPH report that the goal of their analytical research was to compare rates of cervical cancer screening, screening abnormalities, and follow-up care in women with and without a substance use-related diagnosis seen for primary care between January 1, 2016 and December 31, 2019 in the University of Washington healthcare system.

This original research article is brand new to SAj, published online March 15, 2022! Read it now!

Follow us on twitter to stay up to date with new publications!

Filed Under: SAj Blog

New in SAj: Satisfaction with group-based appointments among patients with opioid use disorder in an urban buprenorphine clinic

Mar 2, 2022 by AMERSA

In “Satisfaction with group-based appointments among patients with opioid use disorder in an urban buprenorphine clinic,” authors Serra Akyar, MD, MPH, Amesika Nyaku, MD, MS, Kristyn Lao, MD, Stephanie Ruthberg, MD, MS, and Erin A. Zerbo, MD sought to understand the acceptability of group-based appointments for opioid use disorder (OUD) in an urban clinical setting that treats predominantly ethnic minority populations.

This brief report is brand new to SAj, published online February 28, 2022! Read it now!

Follow us on twitter to stay up to date with new publications!

Filed Under: SAj Blog

The Authors’ Own Words: The Intersection of Intimate Partner Violence and Substance Use Among Women with Opioid Use Disorder

Mar 1, 2022 by AMERSA

In “The Intersection of Intimate Partner Violence and Substance Use Among Women with Opioid Use Disorder,” authors Chelsea Pallatino, PhD, MPH, Judy C. Chang, MD, MPH, and Elizabeth E. Krans, MD, MSc examine the limited understanding of how IPV influences substance use behaviors among women with OUD.

“We chose an open, descriptive qualitative approach using individual interviews to understand the issue of OUD and IPV from the perspectives of women with OUD to avoid imposing our biases or assumptions with any predetermined theoretical framework or pre-determined answer selections.  For our sampling and recruitment, we were able to use infrastructure and staff support from an existing trial that was actively recruiting women who fit characteristics targeted for our sampling.”

You can read this commentary in SAj Volume 42, Issue 2 or online.

Follow us on twitter to stay up to date with new publications!

Filed Under: SAj Blog

New in SAj: Impact of the international collaborative addiction medicine research fellowship on physicians’ future engagement in addiction research

Feb 8, 2022 by AMERSA

In this brief report, authors Jan Klimas, MSc, PhD, Huiru Dong, PhD, Michee-Ana Hamilton, MSc, Walter Cullen, MD, Jeffrey H. Samet, MD, Evan Wood, PhD and Nadia Fairbairn, MD evaluate how an international one-year intensive research training program for addiction medicine physicians contributed to subsequent research involvement and productivity.

Read this article now! and follow us on twitter to stay up to date with new publications!

Filed Under: SAj Blog

New in SAj: Who benefits from Two Way Prayer Meditation? Treatment effect moderators in a pilot randomized controlled trial of a spiritual intervention for people with substance use disorders

Feb 7, 2022 by AMERSA

“Who benefits from Two Way Prayer Meditation? Treatment effect moderators in a pilot randomized controlled trial of a spiritual intervention for people with substance use disorders” was published in the Substance Abuse Journal (SAj) today, February 7, 2022 from Audrey Hang Hai, PhD, Bill Wigmore, BA, Cynthia Franklin, PhD, Clayton Shorkey, PhD, Kirk von Sternberg, PhD, Allan Hugh Cole Jr., PhD, and Diana M. DiNitto, PhD.

This study aimed to identify moderators of two way prayer meditation (TWPM) treatment effects. Moderators tested included gender, race/ethnicity, age, education, religious/spiritual affiliation, and most often used substance. Methods: This study employed a randomized controlled trial design with pretest and posttest. In total, 134 adults in four residential recovery programs participated in the study and were randomly assigned to the TWPM group or the treatment as usual control group.

Read this article now! and follow us on twitter to stay up to date with new publications!

Filed Under: SAj Blog Tagged With: OUD, SUD, treatment

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 88
  • Next Page »

Copyright © 2025
Site by: web360